Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population-Reference-Cited by-同舟云学术

Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population

Published:2019-01-04 Issue:10 Volume:40 Page:809-819
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Kim Tae-Hoon¹,Yang Pil-Sung²,Yu Hee Tae¹,Jang Eunsun¹,Shin Hyejung³,Kim Ha Yan³,Uhm Jae-Sun¹,Kim Jong-Youn¹,Sung Jung-Hoon²,Pak Hui-Nam¹,Lee Moon-Hyoung¹,Joung Boyoung¹,Lip Gregory Y H¹⁴⁵

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50 Yonseiro, Seodaemun-gu, Seoul, Republic of Korea

2. Department of Cardiology, CHA Bundang Medical Center, CHA University, 59, Yatap-ro, Bundang-gu, Seongnam, Gyeonggi-do, Republic of Korea

3. Department of Biomedical Systems Informatics, Biostatistics Collaboration Unit, Yonsei University College of Medicine, 50 Yonseiro, Seodaemun-gu, Seoul, Republic of Korea

4. Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, UK

5. Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK

Funder

Basic Science Research Program

National Research Foundation of Korea

Ministry of Education, Science and Technology

Development of Fundamental Technology Program

Ministry of Science, Information and Communications Technology

ICT

MSIP

Korean Healthcare Technology Research and Development

Ministry of Health & Welfare

Abbott Laboratories

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/10/809/28015567/ehy877.pdf

Reference28 articles.

1. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

2. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

3. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

4. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January;Circulation,2014

5. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur Heart J,2016

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation: comorbidities, lifestyle, and patient factors;The Lancet Regional Health - Europe;2024-02

2. Time in target range of systolic blood pressure and clinical outcomes in atrial fibrillation patients: results of the COOL-AF registry;Scientific Reports;2024-01-08

3. Association of living alone and living alone time with hypertension among Chinese men aged 80 years and older: a cohort study;Frontiers in Public Health;2024-01-05

4. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

5. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01